preview

Bendamustine Hydrochloride Case Study

Decent Essays
Open Document

Bendamustine hydrochloride Dosage of Drug. For patients with CLL, bendamustine hydrochloride is administered as a 30 minute IV infusion on days 1 and 2 of a 28-day cycle for up to six cycles. The recommended dose for the CLL indication is 100 mg/m2. Side Effect of the Drug. Infusion reaction (chills, fever, itching, rash) may require pre-medications, Fever, nausea,vomiting, fatigue, diarrhoea, rash Cyclophosphamide (Cytoxan) Dosage of Drug. Cyclophosphamide 250 mg/m2/day IV on days 1-3 plus (Treatment for patients <70 years or patients who are older without comorbidities and without 11q or 17p deletion) Cyclophosphamide 250 mg/m2/day IV on days 1-3 plus (Treatment recommendations for CLL patients with del (11q)) Side Effect of the Drug. Nausea

Get Access